Cabot Dividend Investor Weekly Update
Earnings have been sensational. Reported earnings for S&P 500 companies have grown an average of 2% in the fourth quarter, compared to an expected -11%.
Read More
Earnings have been sensational. Reported earnings for S&P 500 companies have grown an average of 2% in the fourth quarter, compared to an expected -11%.
Read More
With this week’s recommendation, I’m swinging back to the more conservative side with a solid technology company poised for big gains from the 5G communications rollout.
Read More
Earnings have been sensational. Reported earnings for S&P 500 companies have grown an average of 2% in the fourth quarter, compared to an expected -11%.
Read More
While the rest of the year looks very good for the market, a pullback is likely, if not inevitable, in the weeks and months ahead.
Read More
Stock Name
Market Cap
Price
Investment Type
APi Group (APG)
$3.6 billion
19.25
Growth & Value – Industrial Services
C3.ai (AI)
$14.1 billion
147.17
Rapid Growth – Software
Fisker (FSR)
$5.4billion
19.46
Development Stage – EV Designer
JFrog (FROG)
$6.3 billion
69.23
Rapid Growth – Software
Poshmark (POSH)
$5.4 billion
73.29
Rapid Growth – Resale/Social Platform
Make Hay While the Sun Is Shining
This has been a phenomenal for...
Read More
This week’s recommendation is a small company with no earnings, minimal revenues and a lot of competition.
Read More
The Market is Expensive But Don’t Fight the Tape
Depending on who you follow to get your financial news, you may be aware that the U.S. stock market is quite expensive and there are several warning signs that prospective returns could be weak.
For example, S&P...
Read More
Today I’m swinging back to pure growth with a very interesting stock that has a great story—and no direct competition.
Read More
The Big Idea
There are nearly 6 million men across the U.S. and Europe currently living with prostate cancer. Roughly 625,000 more are added to the list each year. That makes prostate cancer easily one of the most common types of cancer affecting men.
Toss benign...
Read More
The fourth quarter earnings season is well under way and the results have been somewhat spectacular so far, and much better than expected.
Read More
With the now-infamous Reddit trades unraveling, and the rebalancing done, the market is free to rebound.
Read More
The market’s main trend remains up, and thus I continue to recommend that you be heavily invested.
Read More
The market is down today with the Dow falling 400 points so far. It might get uglier before the day is over.
Read More
Overall, the market remains very healthy. Yes, sentiment is a bit high, and yes, valuations are a bit high, but I learned long ago not to fight the trend.
Read More
Stock Name
Market Cap
Price
Investment Type
Arcosa (ACA)
$3.0 billion
62.01
Growth & Value – Infrastructure & Energy
Castle Biosciences (CSTL)
$1.9 billion
81.48
Rapid Growth – Genetic Testing
Certara (CERT)
$5.6 billion
36.60
Growth – Biosimulation Software
Lyft (LYFT)
$15.5 billion
48.94
Rapid Growth – Ridesharing
Purple (PRPL)
$2.2 billion
35.07
Rapid Growth – DTC Mattresses
Still Rallying
As we wade deeper into winter here in Northeast,...
Read More
The market is off to a good start this year and anticipating wonderful things for 2021.
Read More
Overall, the market remains very healthy. Yes, sentiment is a bit high, and yes, valuations are a bit high, but I learned long ago not to fight the trend.
Read More
After years of under-funding, a U.S. infrastructure boom is coming. Here are four stocks and ETFs that stand to benefit most from it.
Read More
How I Pick Micro-Caps
It’s been a while since I’ve explained my process for picking micro-cap stocks so I figured it would be worthwhile to review.
It can be extremely profitable to invest in growth companies, as any Tesla or Amazon shareholder will tell you.
But is...
Read More
The first week of the year saw buyers dominate, pushing the major indexes to higher heights on most days. Thus the major uptrend is intact, but extended, which means this is probably not the best time to buy an aggressive growth stock.
Read More